1. India Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Vivimed Labs Ltd.

Vivimed Labs Ltd.

VIVIMEDLAB.NS
Vivimed Labs Ltd.IN flagNational Stock Exchange of India
5.70
INR
-0.09
- -
472.61MMarket Cap

Total Valuation

Vivimed Labs Ltd. carries a market capitalization of 472.61M, placing it among publicly traded companies globally. Its enterprise value stands at 1.47B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap472.61M
Enterprise Value1.47B

Valuation Ratios

PE RatioN/A
PS Ratio1.75
PB RatioN/A
P/TBV RatioN/A
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

EV / Sales1.75
EV / EBITDAN/A
EV / EBITN/A
EV / FCF38.84

Financial Position

Vivimed Labs Ltd. maintains a current ratio of 1.59, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -1,870.77, indicating conservative leverage, while an interest coverage ratio of -8.08 demonstrates limited ability to service its debt obligations.

Current Ratio1.59
Quick Ratio0.23
Debt / Equity-1,870.77
Debt / EBITDAN/A
Interest Coverage-8.08

Taxes

Income Tax1.13M
Effective Tax RateN/A

Stock Price Statistics

Vivimed Labs Ltd.'s stock has gained approximately 15.15152% over the past 52 weeks. The 50-day moving average sits at 6.35, while the 200-day moving average is 7.19.

Beta (5Y)N/A
52-Week Price Change15.15152%
50-Day Moving Average6.35
200-Day Moving Average7.19
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Vivimed Labs Ltd. generated 836.03M in revenue and converted that into -349.48M in net income, yielding earnings per share of -4.21. EBITDA reached -303.99M, while operating income came in at -303.99M.

Revenue836.03M
Gross Profit415.74M
Operating Income-303.99M
Pretax Income-348.35M
Net Income-349.48M
EBITDA-303.99M
EBIT-303.99M
Earnings Per Share (EPS)-4.21

Margins

Vivimed Labs Ltd. operates with a gross margin of 49.73, reflecting its pricing power and cost economics. The operating margin of -36.36 and net profit margin of -41.80 provide insight into operational efficiency.

Gross Margin49.73
Operating Margin-36.36
Pretax Margin-41.67
Profit Margin-41.80
EBITDA Margin-36.36

Stock Splits

Vivimed Labs Ltd.'s most recent stock split took place on April 6, 2016 with a 1:5 split ratio.

Last Split Date4/6/2016
Split Ratio1:5

Scores

Vivimed Labs Ltd. posts an Altman Z-Score of -0.76, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-0.76